Jubilant Pharmova Limited — Updates, 26-06-2026: General Updates
26-06-2026 | 12:23 am
26-06-2026 | 12:23 am
Jubilant Pharmova's subsidiary, Jubilant Generics, secured USFDA tentative approval for Pantoprazole Sodium Delayed Release Oral Suspension. Final approval awaits the Reference Listed Drug's patent expiry, signaling future market entry.
No comments yet. Be the first to comment!
